BlueCrest Capital Management’s Innoviva INVA Stock Holding History

BlueCrest Capital Management’s Portfolio INVA Stock Details INVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-20,539	Closed	-$288K	–	737
2019 Q1	$288K	Buy	+20,539	New	+$333K	0.01%	727
2018 Q4	–	Sell	-53,381	Closed	-$814K	–	1136
2018 Q3	$814K	Buy	53,381 +7,728	+17%	+$111K	0.02%	531
2018 Q2	$630K	Buy	45,653 +30,791	+207%	+$461K	0.02%	711
2018 Q1	$248K	Buy	14,862 +1,689	+13%	+$26.1K	0.01%	1173
2017 Q4	$187K	Sell	13,173 -20,146	-60%	-$269K	0.01%	721
2017 Q3	$470K	Buy	+33,319	New	+$441K	0.02%	532
2016 Q3	–	Sell	-20,479	Closed	-$216K	–	864
2016 Q2	$216K	Buy	+20,479	New	+$242K	0.01%	777
2016 Q1	–	Sell	-22,416	Closed	-$236K	–	944
2015 Q4	$236K	Buy	+22,416	New	+$206K	0.01%	796

Other funds holding INVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlueCrest Capital Management's INVA Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Innoviva (INVA) in Q2 2019, closing a stake of 20,539 shares — an estimated $288K sold.

BlueCrest Capital Management first reported a position in INVA in Q4 2015 and held it in 8 quarters. The position peaked at $814K in Q3 2018. 217 funds tracked by Wall St. Rank hold INVA as of Q2 2019.

BlueCrest Capital Management reported no remaining Innoviva position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 20,539 Innoviva shares in Q2 2019, an estimated $288K.
BlueCrest Capital Management first reported a position in Innoviva in Q4 2015 and held it in 8 quarters.
BlueCrest Capital Management's Innoviva position peaked at $814K in Q3 2018.
217 funds tracked by Wall St. Rank held Innoviva as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.